Abolished nocturnal blood pressure fall in a boy with glucocorticoid-remediable aldosteronism

Journal of Human Hypertension

Volumn 13, Issue 12, 1999, Pages 823-828

  Seeman, Tomáš ^a   Widimsky J ^b   Hampf, M ^c   Bernhardt, R ^d  

^a UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^d SAARLAND UNIVERSITY   (Germany)

Author keywords

Abolished nocturnal fall; Glucocorticoid remediable aldosteronism; Molecular genetics; Spironolactone

Indexed keywords

ALDOSTERONE; ANTIHYPERTENSIVE AGENT; ATENOLOL; DEXAMETHASONE; ENALAPRIL; GLUCOCORTICOID; MINOXIDIL; NIFEDIPINE; POTASSIUM ION; RENIN; SPIRONOLACTONE;

ADOLESCENT; ALDOSTERONE BLOOD LEVEL; AMBULATORY MONITORING; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; CASE REPORT; CIRCADIAN RHYTHM; CUSHINGOID SYNDROME; HUMAN; HYPERALDOSTERONISM; HYPERTENSION; HYPERTRICHOSIS; HYPOKALEMIA; MALE; NIGHT; PLASMA RENIN ACTIVITY; SIDE EFFECT;

EID: 0033377499     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1000918     Document Type: Article

References (16)

1. DiGeorge AM, Levine LS. Excess mineralocorticoid secretion. In: Nelson WE (ed). Textbook of Pediatrics. Saunders Company: Philadelphia; 1992, pp 1624-1626.
2. Dluhy RG et al. Clinical spectrum of GRA in children. Pediatr Res 1993; 33: 127A.
3. Yiu VWY, Dluhy RP, Lifton RP, Guay-Woodford LM. Low peripheral plasma renin activity as a critical marker in pediatric hypertension. Pediatr Nephrol 1997; 11: 343-346.
4. Lifton RP et al. Chimeric 11β-hydroxylase/aldosterone synthase gene causes GRA and human hypertension. Nature 1992; 355: 262-265.
5. Mancia G et al. Ambulatory blood pressure monitoring. J Hypertens 1996; 14 (Suppl 2): S61-S68.
6. Verdecchia P, Shillacci G, Porcelatti C. Dippers versus non-dippers. J Hypertens 1991; 9 (Suppl 8): 42-44.
7. Report of the Second Task Force on Blood Pressure Control in Children. Pediatrics 1987; 79: 1-25.
8. Soergel M et al. Oscillometric twenty-four-hour ambulatory blood pressure values in healthy children and adolescents: a multicenter trial including 1141 subjects. J Pediatr 1997; 130: 178-184.
9. Peters J, Hampf M, Peters B, Bernhardt R. Molekular-biologie, Klinik und Therapie steroidbedingter Hypertonien. In: Ganten D, Ruckpaul K (eds). Handbuch der Molekularen Medizin. Springer-Verlag, 1998, pp 413-452.
10. Rodd CJ, Sockalosky JJ. Endocrine causes of hypertension in children. Pediatr Clin North Am 1993; 40: 149-164.
11. Stowasser M et al. Clinical, biochemical and genetic approaches to the detection of familial hyperaldosteronism tye I. J Hypertens 1995; 13: 1610-1613.
12. Connel JMC, Inglis GC, Fraser R, Jamieson A. Dexamethasone-suppressible hyperaldosteronism: clinical, biochemical and genetic relations. J Hum Hypertens 1995; 9: 505-509.
13. Rabbia F et al. Fourier analysis of circadian blood pressure profile in secondary hypertension. J Hum Hypertens 1997; 11: 295-299.
14. Penzo M et al. In primary hyperaldosteronism the circadian blood pressure rhythm is similar to that in primary hypertension. Clin Exp Hypertens 1994; 16: 659-673.
15. Mansoor GA, White WB. Circadian blood pressure variation in hypertensive patients with primary hyperaldosteronism. Hypertension 1998; 31: 843-847.
16. Uzu T et al. Changes in the circadian rhythm of blood pressure in primary aldosteronism in response to dietary sodium restriction and adrenalectomy. J Hypertens 1998; 16: 1745-1748.